However, data from a kinetic study in CVID patients showed relatively stable anti-spike IgG antibody levels 4 weeks and 20 weeks after 2 nd COVID-19 vaccination and a positive trend for increased avidity after 3 rd vaccination [ 9 ].
← all excerpts
Impaired B Cell Recall Memory and Reduced Antibody Avidity but Robust T Cell Response in CVID Patients After COVID-19 Vaccination.
2
—
—
The sentences
In CVID NR, 5/6 patients showed an increase but did not reach statistical significance.